DE69837155D1 - Verfahren zum nachweiss von antikörpern in einer probe - Google Patents

Verfahren zum nachweiss von antikörpern in einer probe

Info

Publication number
DE69837155D1
DE69837155D1 DE69837155T DE69837155T DE69837155D1 DE 69837155 D1 DE69837155 D1 DE 69837155D1 DE 69837155 T DE69837155 T DE 69837155T DE 69837155 T DE69837155 T DE 69837155T DE 69837155 D1 DE69837155 D1 DE 69837155D1
Authority
DE
Germany
Prior art keywords
sample
antibodies
present
refreshing
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837155T
Other languages
English (en)
Other versions
DE69837155T2 (de
Inventor
David Y Chien
Phillip Arcangel
Stephen Tirell
Wanda Ziegler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Application granted granted Critical
Publication of DE69837155D1 publication Critical patent/DE69837155D1/de
Publication of DE69837155T2 publication Critical patent/DE69837155T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
DE69837155T 1997-09-22 1998-09-22 Verfahren zum nachweiss von antikörpern in einer probe Expired - Lifetime DE69837155T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5970397P 1997-09-22 1997-09-22
US59703P 1997-09-22
US8392198P 1998-05-01 1998-05-01
US83921P 1998-05-01
PCT/US1998/019693 WO1999015898A1 (en) 1997-09-22 1998-09-22 Method for detecting antibodies in a sample

Publications (2)

Publication Number Publication Date
DE69837155D1 true DE69837155D1 (de) 2007-04-05
DE69837155T2 DE69837155T2 (de) 2007-06-21

Family

ID=26739077

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837155T Expired - Lifetime DE69837155T2 (de) 1997-09-22 1998-09-22 Verfahren zum nachweiss von antikörpern in einer probe

Country Status (12)

Country Link
US (1) US6391540B1 (de)
EP (1) EP1021719B1 (de)
JP (1) JP4124961B2 (de)
AT (1) ATE354800T1 (de)
AU (1) AU9497998A (de)
CA (1) CA2303123C (de)
CY (1) CY1107621T1 (de)
DE (1) DE69837155T2 (de)
DK (1) DK1021719T3 (de)
ES (1) ES2281934T3 (de)
PT (1) PT1021719E (de)
WO (1) WO1999015898A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
ES2279766T3 (es) * 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
DE10006432A1 (de) * 2000-02-14 2001-08-16 Ganzimmun Inst Fuer Ganzheitli Verfahren zum Nachweis von Helicobacter pylori in Stuhl- und Speichelproben
ES2288969T3 (es) * 2000-06-15 2008-02-01 Novartis Vaccines And Diagnostics, Inc. Inmunoensayos para anticuerpos anti-hcv.
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
RU2006140262A (ru) * 2004-04-15 2008-05-20 Эллайд Байотек, Инк. (Us) Способы и устройство для выявления вирусных инфекций
ES2368776T3 (es) 2007-05-08 2011-11-22 F. Hoffmann-La Roche Ag MÉTODO PARA LA DETECCIÓN DE ANTICUERPOS ESPECÍFICOS DE LA CLASE DE INMUNOGLOBULINA G (IgG).
CN105486856A (zh) * 2015-12-24 2016-04-13 泰州泽成生物技术有限公司 一种定性检测丙型肝炎抗体的试剂盒及其制备方法和应用
CN107167584B (zh) * 2017-05-27 2020-03-03 北京热景生物技术股份有限公司 化学发光免疫分析仪
US11959917B2 (en) 2018-09-18 2024-04-16 Siemens Healthcare Diagnostics Inc. Methods and reagents for Zika virus immunoassays

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556840B1 (fr) 1983-12-16 1987-12-24 Immunotech Sa Procede de dosage in vitro des immunoglobulines specifiques d'un ou plusieurs allergenes et reactifs et moyens pour la mise en oeuvre de ce procede
US4737453A (en) 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
ATE92633T1 (de) 1988-05-11 1993-08-15 Abbott Lab Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.
US5656426A (en) 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
KR100206150B1 (ko) * 1990-04-04 1999-07-01 로버트 피. 블랙버언 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
EP0473065A3 (en) * 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
WO1992008979A1 (en) 1990-11-09 1992-05-29 Abbott Laboratories Amplified heterogeneous chemiluminescent immunoassay
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット
JPH06505803A (ja) 1992-01-06 1994-06-30 デイド、インターナショナル、インコーポレイテッド マルチテスト免疫化学的試薬及びその使用方法
JPH06213895A (ja) * 1992-10-16 1994-08-05 Evernew Biotec Inc Ｃ型肝炎の急性期の決定方法
US5395752A (en) 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
AU6508694A (en) * 1993-04-14 1994-11-08 International Murex Technologies Corporation Immunoassay
KR100312534B1 (ko) 1993-04-28 2002-05-13 성재갑 씨(c)형간염및비(b)형간염동시측정면역블롯검정키트및면역블롯검정법
EP0698101B1 (de) * 1993-05-05 2004-11-03 Common Services Agency Hepatitis-c virus typ 4,5 und 6
WO1994026932A1 (en) 1993-05-13 1994-11-24 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nucleic acid tagged immunoassay
DE19502386A1 (de) 1995-01-26 1996-08-01 Boehringer Mannheim Gmbh Stabilisierung von Peptiden und Polypeptiden in immunologischen Tests durch Zusatz von kleinen Hitzeschockproteinen
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
DE69734776T2 (de) * 1996-05-24 2006-08-17 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Fusionsprotein mit multiplen Epitopen

Also Published As

Publication number Publication date
CY1107621T1 (el) 2013-03-13
AU9497998A (en) 1999-04-12
DE69837155T2 (de) 2007-06-21
ES2281934T3 (es) 2007-10-01
EP1021719B1 (de) 2007-02-21
JP4124961B2 (ja) 2008-07-23
CA2303123A1 (en) 1999-04-01
PT1021719E (pt) 2007-03-30
ATE354800T1 (de) 2007-03-15
EP1021719A1 (de) 2000-07-26
US6391540B1 (en) 2002-05-21
JP2001517797A (ja) 2001-10-09
DK1021719T3 (da) 2007-06-18
CA2303123C (en) 2006-04-11
WO1999015898A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
NZ306051A (en) Testing using electrochemiluminescence
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
DE69835893D1 (de) Diagnostische tests und kits für clostridium difficile
DE69719057D1 (de) Verfahren zur signalverstärkung
NO860400L (no) Dual hybridiseringsanalyse i opploesningsfase for detektering av polynukleotide sekvenser.
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
DE69513649D1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
DE69428998D1 (de) Reagenzien und verfahren zur detektion und quantitativen bestimmung von testosteron in flüssigen proben
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
DE60028374D1 (de) Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays
DE69632826D1 (de) Nukleinsaeure erkennung von hepatitis gb virus
DE69529691D1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
ATE188551T1 (de) Feststellung von antikörperproduktion
DE60038557D1 (en) Assay
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
DE60216482D1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
ATE188037T1 (de) Verfahren zum immunochemischen nachweis des ursprungs einer gentechnologisch hergestellten substanz und reagenzien dafür

Legal Events

Date Code Title Description
8364 No opposition during term of opposition